AKT1 and triple-negative breast carcinoma: Another study based on triple-negative breast cancer cells reported that myricetin modulated pro-angiogenic, cell cycle, and invasion effects through the PI3K/Protein kinase B (PKB/also known as AKT) and MAPK signaling pathways [77].